Effect of tiotropium on exhaled breath temperature in patients with COPD

T. Kralimarkova, P. Georgieva, E. Mekov, D. Nedeva, V. Dimitrov, T. Popov (Sofia, Bulgaria)

Source: Annual Congress 2013 –COPD drugs: new findings
Session: COPD drugs: new findings
Session type: Thematic Poster Session
Number: 4140
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kralimarkova, P. Georgieva, E. Mekov, D. Nedeva, V. Dimitrov, T. Popov (Sofia, Bulgaria). Effect of tiotropium on exhaled breath temperature in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 4140

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015


Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014


Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


The adherence to inhaled drugs in COPD patients: Effect on survival
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients
Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Year: 2012



Measurement of exhaled breath temperature (EBT) in COPD patients
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Estimation of tiotropium efficacy at the COPD patients with group D
Source: International Congress 2015 – Different data in COPD
Year: 2015


The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Monitoring exhaled carbon monoxide in COPD exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Effects of ciclesonide on the management of stable COPD with airway eosinophilia
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013